KLP Kapitalforvaltning AS acquired a new stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,600 shares of the medical equipment provider's stock, valued at approximately $875,000.
Several other large investors have also modified their holdings of the stock. Lee Danner & Bass Inc. acquired a new position in Integer during the fourth quarter worth approximately $27,000. HUB Investment Partners LLC acquired a new stake in shares of Integer during the 4th quarter worth $219,000. Xponance Inc. increased its holdings in shares of Integer by 9.5% during the 4th quarter. Xponance Inc. now owns 2,396 shares of the medical equipment provider's stock worth $318,000 after buying an additional 207 shares during the last quarter. Intech Investment Management LLC raised its position in shares of Integer by 51.1% in the 4th quarter. Intech Investment Management LLC now owns 11,767 shares of the medical equipment provider's stock worth $1,559,000 after buying an additional 3,980 shares during the period. Finally, Cibc World Markets Corp acquired a new position in Integer in the fourth quarter valued at $413,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.
Integer Stock Down 1.9 %
Integer stock traded down $2.20 during midday trading on Friday, hitting $113.87. 1,211,284 shares of the stock were exchanged, compared to its average volume of 332,815. Integer Holdings Co. has a 1 year low of $107.11 and a 1 year high of $146.36. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market cap of $3.83 billion, a P/E ratio of 33.89, a P/E/G ratio of 1.72 and a beta of 1.24. The company has a 50 day moving average price of $128.00 and a two-hundred day moving average price of $131.73.
Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million for the quarter, compared to analysts' expectations of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. On average, sell-side analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
ITGR has been the topic of a number of research reports. KeyCorp raised their price objective on Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a report on Friday, February 21st. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Citigroup increased their price objective on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research report on Wednesday, December 11th. Finally, Raymond James began coverage on shares of Integer in a report on Friday, March 28th. They set an "outperform" rating and a $145.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $148.56.
View Our Latest Analysis on Integer
Integer Company Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
